Surgical outcomes in women with ovarian cancer

Canadian Journal of Surgery

Volumn 51, Issue 5, 2008, Pages 346-354

  Elit, Laurie M ^a,f   Bondy, Susan J ^b,c   Paszat, Lawrence P ^b,c,d   Holowaty, Eric J ^e   Thomas, Gillian M ^d   Stukel, Therese A ^b,c   Levine, Mark N ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CANCER CARE ONTARIO   (Canada)

^f JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53549100471     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Giede KC, Keiser K, Dodge J, et al. Who should operate on patients with ovarian cancer? An evidence-based review. Gynecol Oncol 2005;99:447-61.
2. Junor E. The impact of specialist training for surgery in ovarian cancer. Int J Gynecol Cancer 2000;10:16-8.
3. Eisenkop SM, Spirtos NM, Montag TW, et al. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 1992;47:203-9.
4. Kehoe S, Powell J, Wilson S, et al. The influence of the operating surgeon's specialization on patient survival in ovarian carcinoma. Br J Cancer 1994;70:1014-7.
5. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer 1994;70:363-70.
6. Hole DJ, Gillis CR. Use of cancer registry data to evaluate the treatment of ovarian cancer on a hospital basis. Health Rep 1993;5:117-9.
7. Nguyen HN, Averette HE, Hoskins W, et al. National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system. Cancer 1993;72:3007-11.
8. Mayer AR, Chambers SK, Graves E, et al. Ovarian cancer staging: Does it require a gynecologic oncologist? Gynecol Oncol 1992;47:223-7.
9. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol 1997;15:3408-15.
10. Puls LE, Carrasco R, Morrow MS, et al. Stage 1 ovarian carcinoma: specialty-related differences in survival and management. South Med J 1997;90:1097-100.
11. Piver MS. Systematic surgical saging: stage I ovarian cancer. J Clin Oncol 1997;15:864-5.
12. Grant PT, Beischer NA, Planner RS. The treatment of gynaecological malignancy in a general public hospital. Med J Aust 1992;157:378-80.
13. Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA 1983;250:3072-6.
14. Piver MS. Specialized surgery in ovarian cancer. Eur J Cancer Clin Oncol 1987;23:123-5.
15. Elit L, Bondy SJ, Paszat L, et al. Outcomes in surgery for ovarian cancer. Gynecol Oncol 2002;87:260-7.
16. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
17. Trimbos JB, Vergote IB, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemotherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 2003;95:113-25.
18. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
19. Trimbos JB, Schueler JA, van Lent M, et al. Reasons for incomplete surgical staging in early ovarian carcinoma. Gynecol Oncol 1990;37:374-7.
20. Trimbos JB, Parmar M, Vergote IB, et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
21. Gagliardi AR, Fung MGK, Langer B, et al. Development of ovarian cancer surgery quality indicators using a modified Delphi approach. Gynecol Oncol 2005;97:446-56.